Bayer spends $1.2bn on supplement maker

German healthcare giant Bayer has struck a deal to buy Schiff Nutrition, a US company specialising in vitamins and nutritional supplements, for $1.2 billion (£740 million).

Schiff was worth $259 million in sales in its 2011-12 financial year and currently employs 400 people at its headquarters and manufacturing site in Salt Lake City, Utah, and offices in Emeryville, California.

‘The Schiff business significantly enhances our presence and position in the US, which accounts for more over-the-counter and nutritional products sales than any other country in the world,’ said Bayer chief executive Marijn Dekkers.

The Schiff portfolio includes big brands in the joint care (Move Free), cardiovascular health (MegaRed) and immune support (Airborne) markets.


Related Content

Reckitt steps into Schiff deal

19 November 2012 Business

news image

Higher bid could sink Bayer's $1.2bn attempt to buy vitamins and nutritional supplements company

Schiff seals deal with Reckitt

23 November 2012 Business

news image

Boards approves $1.4 billion Reckitt offer as Bayer pulls out of running

Most Read

Growing a microgarden

17 May 2013 Research

news image

Barium carbonate crystals have been coaxed to form nano-flowers by controlling their chemical environment

Sugar solution to toxic gold recovery

15 May 2013 Research

news image

The environmental legacy of salvaging gold from electronic waste can be dramatically cut using corn starch instead of cyanide

Most Commented

DCD in New Zealand milk

31 January 2013 Business

news image

Dicyandiamide poses no food risk but fertiliser companies have suspended sales

3D printer churns out bionic ear

17 May 2013 Research

news image

Seamless integration of electronics and tissue could be used with other artificial implants and synthetic organs